Statement by FDA Commissioner Scott Gottlieb, M.D., Director of FDA ’ s Center for Drug Evaluation and Research Janet Woodcock, M.D. and Director of FDA ’ s Center for Biologics Evaluation and Research Peter Marks, M.D. on Expanded Access – Looking Forward

Helping to facilitate access to promising medicines for patients with serious or immediately life-threatening diseases or conditions when no comparable or satisfactory alternative therapy options are available is a high priority for the FDA.
Source: Food and Drug Administration - Category: American Health Source Type: news